Phase IV, Open Label, Non-comparative, Multi-center, Study of the Effects of Both Insulin Glargine and Insulin Glulisine in Type I Diabetes Mellitus Patients.
Phase of Trial: Phase IV
Latest Information Update: 11 Sep 2009
At a glance
- Drugs Insulin glargine; Insulin glulisine
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Acronyms GLANS
- Sponsors Sanofi
- 31 Aug 2018 Biomarkers information updated
- 11 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 Sep 2009 Actual initiation date changed from Jul 2007 to Apr 2007 as reported by ClinicalTrials.gov.